$RLFTF $NRXP DD (opinion) by Mt on Yh0 - Maybe not
Post# of 653
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179120/
"Currently, two available commercial dosage forms of synthetic VIP (Aviptadil in intravenous and inhaled formulation) are under two clinical trials for COVID-19 patients with respiratory failure (clinicaltrials.gov: NCT04311697 and NCT04360096).
Considering all the above-mentioned advantages, besides the exceptional safety profile of VIP and the affordable manufacturing of its synthetic forms, VIP could have the potential as a preventive measure and even therapeutic agent for patients with COVID-19 infection."
Critical covid is only the first step.